Hycult Biotech

Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.

sample review
  • Hycult Biotechnology anti-F4/80 antibody was used to perform immunocytochemistry in order to study the characteristics of the proliferating mesodermal cells in murine embryos.
  • Hycult Biotechnology monoclonal anti-hCAP-18/LL-37 antibody(1:50) was used to perform immunohistochemistry in order to investigate the role of hCAP-18/LL-37 in human ovarian cancer progression.
  • HyCult anti-CD284 monoclonal antibody was used to perform flow cytometry in order to study the antimicrobial peptide hLF1-11 affected human monocyte-macrophage differentiation.
  • HyCult anti-CD282 monoclonal antibody was used to perform flow cytometry in order to study the antimicrobial peptide hLF1-11 affected human monocyte-macrophage differentiation.
  • Hycult Biotechnology anti-SKALP was used to perform immunohistochemistry in dilution 1:1600 in order to show that dermal components express differentially between human fetal and adult skin and play important roles in fetal scarless healing.
  • Hycult anti-IL-8 was used to perform ELISA in order to show that plasma thioredoxin levels is associated with macrophage migration inhibitory factor positively in patients with sepsis.
  • Hycult anti-IL-6 was used to perform ELISA in order to show that plasma thioredoxin levels is associated with macrophage migration inhibitory factor positively in patients with sepsis.
  • Hycult Biotechnology anti-mouse MPO was used to perform ELISA in order to show that resolution of inflammation is promoted by tissue inhibitor of metalloproteinases 3 after acute lung injury.
  • HyCult biotechnology rat anti-mouse C3 (1:50) antibody was used to perform immunohistochemistry in order to investigate the role of HLA-DQ2 in the pathogenesis of associated immune disorders.
  • Hycult-Biotechnologies anti-CD46 mouse monoclonal antibody was used to perform western blot and flow cytometry in order to study the function of CD147/EMMPRIN as a receptor for measles virus on epithelial cells.
  • Covance anti-Amyloid beta monoclonal antibody (4G8, 1:200 dilution) was used to perform western blot and immunoprecipitation in order to clarify that amyloid beta is an antimicrobial peptide that may normally function in the innate immune system.
sample product